Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PepGen Inc. (PEPG)
USD2.43
-0.02 (-0.61%)
US NASDAQ Healthcare Biotechnology
Address
321 Harrison Avenue 2118
Boston, MA, US
Boston, MA, US
CEO
James McArthur
Website
pepgen.com
IPO
2022-05-06
CIK 1835597 ISIN US7133171055
Description
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.43
-0.02 (-0.61%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
894.3K
Beta
1.93
Float Shares
37.03M
Free Float %
53.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -1.32% | -8.54% | -75.88% | -76.71% | -76.96% | +4.17% | -89.99% | -88.36% | -88.36% | -88.36% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (6 ratings, all time)
Buy
Price Targets & DCF
Current price
2.43
Low
4.00
+64.9%
Consensus
5.50
+126.8%
Median
5.50
+126.8%
High
7.00
+188.7%
DCF (Unlevered)
1.01
-58.2%
DCF (Levered)
1.03
-57.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
86% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
4.00
+64.9%
|
| Last Quarter | 1 |
4.00
+64.9%
|
| Last Year | 5 |
10.00
+312.4%
|
| All Time | 7 |
15.57
+542.1%
|
Quality scores
Altman Z-Score
-1.36
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+25.6% Q1'26: +54.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-585.4% Q1'26: -415.4% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+33.7% Q1'26: +29.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.18× Q1'26: -0.22× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 3 Rev. Ana. 6 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
est: 4.00M (-100.0%)
|
37.46M
37.46M – 37.46M
+837.5% YoY
|
4.61M
4.61M – 4.61M
-87.7% YoY
|
31.13M
31.13M – 31.13M
+574.9% YoY
|
28.87M
28.87M – 28.87M
-7.3% YoY
|
73.04M
73.04M – 73.04M
+153.0% YoY
|
| EBITDA |
-89.09M
|
-92.22M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-90.60M
|
-93.61M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-89.98M
est: -96.92M (+7.2%)
|
-89.66M
est: -77.22M (-16.1%)
|
-50.28M
-61.15M – -39.40M
+34.9% YoY
|
-62.41M
-88.44M – -36.37M
-24.1% YoY
|
-55.69M
-77.69M – -33.68M
+10.8% YoY
|
-37.86M
-37.86M – -37.86M
+32.0% YoY
|
-14.07M
-14.07M – -14.07M
+62.8% YoY
|
| SGA |
21.26M
|
22.57M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-2.85
est: -2.73 (-4.4%)
|
-2.12
est: -2.27 (+6.4%)
|
-1.15
-1.45 – -0.93
+49.4% YoY
|
-1.32
-2.09 – -0.86
-15.2% YoY
|
-1.17
-1.84 – -0.80
+11.5% YoY
|
-0.90
-0.90 – -0.90
+23.4% YoY
|
-0.33
-0.33 – -0.33
+62.8% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-13 | Wedbush | Outperform | Outperform | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-14 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
102
Total invested
98.32M
Insider transactions (90d)
1
Beneficial owners (>5%)
28
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Peter Kolchinsky | 8.13M | 36.30% | — | 8.13M | — | 10.00 | HC, IN | United States | 2022-05-20 | ↗ |
| 2 | RA Capital Management, L.P. | 8.13M | 36.30% | — | 8.13M | — | 10.00 | IA, PN | Delaware | 2022-05-20 | ↗ |
| 3 | Rajeev Shah | 8.13M | 36.30% | — | 8.13M | — | 10.00 | HC, IN | United States | 2022-05-20 | ↗ |
| 4 | RA Capital Healthcare Fund, L.P. | 6.62M | 25.60% | — | 6.62M | — | 10.00 | PN | Delaware | 2022-05-20 | ↗ |
| 5 | 2 | 4.76M | 14.70% | 4.76M | — | 4.76M | — | CO | England, United Kingdom | 2024-04-09 | ↗ |
| 6 | EIN #00-0000000 | 2.34M | 7.20% | — | 2.34M | — | 2.34M | IA, HC | Jersey, Channel Islands | 2024-11-14 | ↗ |
| 7 | Abigail P. Johnson | 2.19M | 9.28% | — | — | 2.19M | — | IN | United States of America | 2023-02-09 | ↗ |
| 8 | FMR LLC | 2.19M | 9.28% | 2.19M | — | 2.19M | — | HC | Delaware | 2023-02-09 | ↗ |
| 9 | 00-0000000 | 2.14M | 6.60% | — | 2.14M | — | 2.14M | IV | Massachusetts | 2024-11-14 | ↗ |
| 10 | David C. Ott | 1.79M | 8.00% | — | 1.79M | — | 1.79M | IN | Delaware | 2022-05-20 | ↗ |
| 11 | O. Andreas Halvorsen | 1.79M | 8.00% | — | 1.79M | — | 1.79M | IN | Delaware | 2022-05-20 | ↗ |
| 12 | Rose S. Shabet | 1.79M | 8.00% | — | 1.79M | — | 1.79M | IN | Delaware | 2022-05-20 | ↗ |
| 13 | Viking Global Investors LP | 1.79M | 8.00% | — | 1.79M | — | 1.79M | PN | Delaware | 2022-05-20 | ↗ |
| 14 | Viking Global Opportunities GP LLC | 1.79M | 8.00% | — | 1.79M | — | 1.79M | OO | Delaware | 2022-05-20 | ↗ |
| 15 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 1.79M | 8.00% | — | 1.79M | — | 1.79M | PN | Delaware | 2022-05-20 | ↗ |
| 16 | Viking Global Opportunities Parent GP LLC | 1.79M | 8.00% | — | 1.79M | — | 1.79M | OO | Delaware | 2022-05-20 | ↗ |
| 17 | Viking Global Opportunities Portfolio GP LLC | 1.79M | 8.00% | — | 1.79M | — | 1.79M | OO | Delaware | 2022-05-20 | ↗ |
| 18 | Aaron Cowen | 1.66M | 5.10% | — | 1.66M | — | 1.66M | HC, IN | Delaware | 2024-08-12 | ↗ |
| 19 | Averill Master Fund, Ltd. | 1.66M | 5.10% | — | 1.66M | — | 1.66M | CO | Delaware | 2024-08-12 | ↗ |
| 20 | Suvretta Capital Management, LLC | 1.66M | 5.10% | — | 1.66M | — | 1.66M | IA, OO | Delaware | 2024-08-12 | ↗ |
| 21 | Qatar Investment Authority | 1.25M | 5.59% | — | — | — | — | OO | Qatar | 2022-05-13 | ↗ |
| 22 | KAVRA 16 LLC | 1.07M | 4.80% | — | 1.07M | — | 1.07M | PN | Delaware | 2022-05-20 | ↗ |
| 23 | Company, L.P. | 953.6K | 4.26% | — | 953.6K | — | — | PN | Delaware | 2022-05-10 | ↗ |
| 24 | James E. Flynn | 953.6K | 4.26% | — | 953.6K | — | — | IN | Delaware | 2022-05-10 | ↗ |
| 25 | Deerfield Mgmt V, L.P. | 476.8K | 2.13% | — | 476.8K | — | — | PN | Delaware | 2022-05-10 | ↗ |
| 26 | Deerfield Mgmt, L.P. | 476.8K | 2.13% | — | 476.8K | — | — | PN | Delaware | 2022-05-10 | ↗ |
| 27 | Deerfield Partners, L.P. | 476.8K | 2.13% | — | 476.8K | — | — | PN | Delaware | 2022-05-10 | ↗ |
| 28 | Deerfield Private Design Fund V, L.P. | 476.8K | 2.13% | — | 476.8K | — | — | PN | Delaware | 2022-05-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
102
+11 vs prev Q
New positions
29
Closed positions
21
Increased
56
Reduced
26
Put/Call ratio
0.11
Calls held
1.07M
Puts held
117.3K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 20.06M +— (+0.0%) | 130.62M +37.9M (+40.9%) | 61.27% +0.000 pp | 1.34% +0.196 pp | USD8.03 -18.9% | 15 qtrs — |
| 2 | VIKING GLOBAL INVESTORS LP | 3.48M +— (+0.0%) | 22.67M +6.6M (+40.9%) | 10.63% +0.000 pp | 0.06% +0.018 pp | USD6.88 -5.4% | 15 qtrs — |
| 3 | COMMODORE CAPITAL LP | 3.40M +1.0M (+44.2%) | 22.13M +11.2M (+103.2%) | 10.38% +3.184 pp | 1.47% +0.942 pp | USD5.20 +25.2% | 2 qtrs — |
| 4 | VIVO CAPITAL, LLC | 2.33M +— (+0.0%) | 15.14M +4.4M (+40.9%) | 7.10% +0.000 pp | 0.98% +0.114 pp | USD4.62 +40.9% | 2 qtrs — |
| 5 | POINT72 ASSET MANAGEMENT, L.P. | 2.27M +244.4K (+12.0%) | 14.81M +5.4M (+57.9%) | 6.95% +0.746 pp | 0.02% +0.001 pp | USD1.95 +233.8% | 4 qtrs — |
| 6 | VANGUARD GROUP INC | 2.21M +444.5K (+25.1%) | 14.41M +6.2M (+76.3%) | 6.76% +1.357 pp | 0.00% +0.000 pp | USD8.03 -18.9% | 15 qtrs — |
| 7 | LAURION CAPITAL MANAGEMENT LP | 2.05M +160.0K (+8.5%) | 13.36M +4.6M (+52.8%) | 6.27% +0.489 pp | 0.50% +0.347 pp | USD7.24 -10.1% | 15 qtrs — |
| 8 | BVF INC/IL | 1.92M +— (+0.0%) | 12.47M +3.6M (+40.9%) | 5.85% +0.000 pp | 0.42% +0.061 pp | USD4.62 +40.9% | 2 qtrs — |
| 9 | NANTAHALA CAPITAL MANAGEMENT, LLC | 1.55M +1.5M (+100.0%) | 10.07M +10.1M (+100.0%) | 4.72% +4.725 pp | 0.33% +0.333 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 10 | JANUS HENDERSON GROUP PLC | 1.50M +— (+0.0%) | 9.80M +2.9M (+41.6%) | 4.58% +0.000 pp | 0.00% +0.001 pp | USD4.62 +40.9% | 2 qtrs — |
| 11 | PICTET ASSET MANAGEMENT HOLDING SA | 1.35M +871.1K (+181.0%) | 8.80M +6.6M (+295.9%) | 4.13% +2.660 pp | 0.01% +0.006 pp | USD5.84 +11.5% | 2 qtrs — |
| 12 | WOODLINE PARTNERS LP | 1.31M +— (+0.0%) | 8.53M +2.5M (+40.9%) | 4.00% +0.000 pp | 0.03% +0.005 pp | USD2.93 +122.2% | 4 qtrs — |
| 13 | AWM INVESTMENT COMPANY, INC. | 1.30M +275.0K (+26.8%) | 8.46M +3.7M (+78.7%) | 3.97% +0.840 pp | 0.82% +0.373 pp | USD5.02 +29.7% | 2 qtrs — |
| 14 | BLACKROCK, INC. | 1.23M +784.3K (+174.2%) | 8.04M +6.0M (+286.4%) | 3.77% +2.395 pp | 0.00% +0.000 pp | USD6.97 -6.6% | 6 qtrs — |
| 15 | MORGAN STANLEY | 1.08M +509.2K (+88.5%) | 7.06M +4.4M (+165.7%) | 3.31% +1.555 pp | 0.00% +0.000 pp | USD5.49 +18.6% | 15 qtrs — |
| 16 | BALYASNY ASSET MANAGEMENT L.P. | 866.3K -467.3K (-35.0%) | 5.64M -521.7K (-8.5%) | 2.65% -1.427 pp | 0.01% -0.001 pp | USD4.62 +40.9% | 2 qtrs — |
| 17 | PERCEPTIVE ADVISORS LLC | 829.9K +— (+0.0%) | 5.40M +1.6M (+40.9%) | 2.53% +0.000 pp | 0.10% -0.014 pp | USD4.62 +40.9% | 2 qtrs — |
| 18 | OCTAGON CAPITAL ADVISORS LP | 700.0K +— (+0.0%) | 4.56M +1.3M (+40.9%) | 2.14% +0.000 pp | 0.55% +0.063 pp | USD4.62 +40.9% | 2 qtrs — |
| 19 | SIREN, L.L.C. | 700.0K +— (+0.0%) | 4.56M +1.3M (+40.9%) | 2.14% +0.000 pp | 0.14% +0.009 pp | USD4.62 +40.9% | 2 qtrs — |
| 20 | GEODE CAPITAL MANAGEMENT, LLC | 542.1K +341.4K (+170.1%) | 3.53M +2.6M (+280.6%) | 1.66% +1.042 pp | 0.00% +0.000 pp | USD8.83 -26.3% | 15 qtrs — |
| 21 | BOOTHBAY FUND MANAGEMENT, LLC | 418.0K +67.6K (+19.3%) | 2.72M +1.1M (+68.1%) | 1.28% +0.207 pp | 0.04% +0.017 pp | USD4.58 +42.1% | 4 qtrs — |
| 22 | BOXER CAPITAL MANAGEMENT, LLC | 373.9K +123.9K (+49.6%) | 2.43M +1.3M (+110.7%) | 1.14% +0.378 pp | 0.53% +0.165 pp | USD5.25 +24.0% | 2 qtrs — |
| 23 | BANK OF AMERICA CORP /DE/ | 351.1K +348.5K (+12,977.9%) | 2.29M +2.3M (+18,329.0%) | 1.07% +1.064 pp | 0.00% +0.000 pp | USD6.55 -0.6% | 15 qtrs — |
| 24 | DRIEHAUS CAPITAL MANAGEMENT LLC | 315.0K +— (+0.0%) | 2.05M +595.4K (+40.9%) | 0.96% +0.000 pp | 0.01% +0.004 pp | USD4.62 +40.9% | 2 qtrs — |
| 25 | IKARIAN CAPITAL, LLC | 300.0K +300.0K (+100.0%) | 1.95M +2.0M (+100.0%) | 0.92% +0.916 pp | 0.15% +0.153 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 26 | MARSHALL WACE, LLP | 290.6K +290.6K (+100.0%) | 1.89M +1.9M (+100.0%) | 0.89% +0.887 pp | 0.00% +0.002 pp | USD6.51 +0.0% | 3 qtrs — |
| 27 | CITADEL ADVISORS LLC | 267.8K -29.5K (-9.9%) | 1.74M +370.0K (+26.9%) | 0.82% -0.090 pp | 0.00% +0.000 pp | USD4.62 +40.9% | 5 qtrs — |
| 28 | TWO SIGMA INVESTMENTS, LP | 267.4K +174.9K (+189.1%) | 1.74M +1.3M (+307.4%) | 0.82% +0.534 pp | 0.00% +0.002 pp | USD5.07 +28.4% | 6 qtrs — |
| 29 | WALLEYE CAPITAL LLC | 256.0K +256.0K (+100.0%) | 1.67M +1.7M (+100.0%) | 0.78% +0.782 pp | 0.01% +0.005 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 30 | GOLDMAN SACHS GROUP INC | 241.6K +241.6K (+100.0%) | 1.57M +1.6M (+100.0%) | 0.74% +0.738 pp | 0.00% +0.000 pp | USD6.51 +0.0% | 13 qtrs — |
| 31 | STATE STREET CORP | 217.5K +151.7K (+230.6%) | 1.42M +1.1M (+365.8%) | 0.66% +0.463 pp | 0.00% +0.000 pp | USD8.33 -21.8% | 15 qtrs — |
| 32 | ARTIA GLOBAL PARTNERS LP | 205.3K +205.3K (+100.0%) | 1.34M +1.3M (+100.0%) | 0.63% +0.627 pp | 0.21% +0.213 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 33 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 205.1K +186.9K (+1,026.9%) | 1.34M +1.3M (+1,487.9%) | 0.63% +0.571 pp | 0.00% +0.000 pp | USD6.34 +2.7% | 2 qtrs — |
| 34 | MILLENNIUM MANAGEMENT LLC | 197.9K -302.3K (-60.4%) | 1.29M -1.0M (-44.2%) | 0.60% -0.923 pp | 0.00% 0.000 pp | USD1.61 +304.3% | 6 qtrs — |
| 35 | JANE STREET GROUP, LLC | 192.7K +192.7K (+100.0%) | 1.25M +1.3M (+100.0%) | 0.59% +0.589 pp | 0.00% +0.000 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 36 | 683 CAPITAL MANAGEMENT, LLC | 186.9K +186.9K (+100.0%) | 1.22M +1.2M (+100.0%) | 0.57% +0.571 pp | 0.05% +0.053 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 37 | POLYMER CAPITAL MANAGEMENT (HK) LTD | 160.0K +160.0K (+100.0%) | 1.04M +1.0M (+100.0%) | 0.49% +0.489 pp | 0.15% +0.148 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 38 | RENAISSANCE TECHNOLOGIES LLC | 147.9K +72.2K (+95.4%) | 962.8K +613.1K (+175.3%) | 0.45% +0.221 pp | 0.00% +0.001 pp | USD4.42 +47.3% | 7 qtrs — |
| 39 | MONIMUS CAPITAL MANAGEMENT, LP | 138.4K +33.6K (+32.1%) | 901.0K +416.8K (+86.1%) | 0.42% +0.103 pp | 0.59% +0.296 pp | USD5.08 +28.1% | 2 qtrs — |
| 40 | DIMENSIONAL FUND ADVISORS LP | 135.2K +102.2K (+309.7%) | 880.1K +727.6K (+477.1%) | 0.41% +0.312 pp | 0.00% +0.000 pp | USD6.77 -3.8% | 6 qtrs — |
| 41 | SPHERA FUNDS MANAGEMENT LTD. | 121.5K -50.0K (-29.2%) | 790.8K -1.4K (-0.2%) | 0.37% -0.153 pp | 0.15% -0.014 pp | USD1.42 +358.5% | 3 qtrs — |
| 42 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 120.7K -69.5K (-36.5%) | 785.9K -93.0K (-10.6%) | 0.37% -0.212 pp | 0.01% -0.003 pp | USD4.62 +40.9% | 2 qtrs — |
| 43 | NORTHERN TRUST CORP | 118.3K +58.7K (+98.7%) | 769.9K +494.8K (+179.9%) | 0.36% +0.179 pp | 0.00% +0.000 pp | USD7.95 -18.1% | 15 qtrs — |
| 44 | READYSTATE ASSET MANAGEMENT LP | 113.5K +113.5K (+100.0%) | 738.9K +738.9K (+100.0%) | 0.35% +0.347 pp | 0.03% +0.030 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 45 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 100.0K -1.4M (-93.1%) | 651.0K -6.0M (-90.3%) | 0.31% -4.122 pp | 0.00% -0.010 pp | USD5.90 +10.3% | 15 qtrs — |
| 46 | XTX TOPCO LTD | 98.0K +98.0K (+100.0%) | 638.2K +638.2K (+100.0%) | 0.30% +0.299 pp | 0.02% +0.017 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 47 | RBF CAPITAL, LLC | 95.0K -5.0K (-5.0%) | 618.7K +156.7K (+33.9%) | 0.29% -0.015 pp | 0.03% +0.007 pp | USD1.11 +486.5% | 3 qtrs — |
| 48 | BNP PARIBAS ARBITRAGE, SNC | 89.6K +88.2K (+6,316.5%) | 583.1K +576.7K (+8,940.8%) | 0.27% +0.269 pp | 0.00% +0.000 pp | USD6.44 +1.1% | 5 qtrs — |
| 49 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 73.3K +35.2K (+92.5%) | 477.2K +301.3K (+171.3%) | 0.22% +0.108 pp | 0.00% +0.001 pp | USD5.53 +17.7% | 2 qtrs — |
| 50 | HUDSON BAY CAPITAL MANAGEMENT LP | 69.4K +69.4K (+100.0%) | 451.7K +451.7K (+100.0%) | 0.21% +0.212 pp | 0.00% +0.002 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 51 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63.0K +— (+0.0%) | 410.1K +119.1K (+40.9%) | 0.19% +0.000 pp | 0.01% +0.002 pp | USD3.39 +92.0% | 10 qtrs — |
| 52 | BARCLAYS PLC | 55.7K +33.7K (+153.6%) | 362.7K +174.9K (+93.1%) | 0.17% +0.103 pp | 0.00% +0.000 pp | USD5.96 +9.2% | 15 qtrs — |
| 53 | JUMP FINANCIAL, LLC | 55.4K +55.4K (+100.0%) | 360.9K +360.9K (+100.0%) | 0.17% +0.169 pp | 0.00% +0.004 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 54 | RESOLUTE CAPITAL ASSET PARTNERS LLC | 50.0K +50.0K (+100.0%) | 325.5K +325.5K (+100.0%) | 0.15% +0.153 pp | 0.16% +0.157 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 55 | GSA CAPITAL PARTNERS LLP | 43.4K -2.7K (-5.9%) | 283.0K +70.0K (+32.9%) | 0.13% -0.008 pp | 0.02% +0.007 pp | USD4.62 +40.9% | 2 qtrs — |
| 56 | SIMPLEX TRADING, LLC | 43.2K +43.2K (+100.0%) | 281.2K +281.2K (+100.0%) | 0.13% +0.132 pp | 0.00% +0.000 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 57 | ADAR1 CAPITAL MANAGEMENT, LLC | 36.8K +— (+0.0%) | 239.8K +69.6K (+40.9%) | 0.11% +0.000 pp | 0.02% +0.002 pp | USD2.85 +128.4% | 4 qtrs — |
| 58 | RANGELEY CAPITAL, LLC | 36.2K -7.8K (-17.7%) | 235.7K +32.4K (+15.9%) | 0.11% -0.024 pp | 0.20% +0.020 pp | USD1.93 +237.3% | 4 qtrs — |
| 59 | LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 36.1K +36.1K (+100.0%) | 235.2K +235.2K (+100.0%) | 0.11% +0.110 pp | 0.02% +0.016 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 60 | RATHBONES GROUP PLC | 32.0K +— (+0.0%) | 208.3K +60.5K (+40.9%) | 0.10% +0.000 pp | 0.00% +0.000 pp | USD5.08 +28.1% | 10 qtrs — |
| 61 | CITIGROUP INC | 31.3K +29.8K (+1,997.5%) | 204.0K +197.1K (+2,855.3%) | 0.10% +0.091 pp | 0.00% +0.000 pp | USD6.66 -2.3% | 15 qtrs — |
| 62 | QUBE RESEARCH & TECHNOLOGIES LTD | 31.2K +31.2K (+100.0%) | 203.3K +203.3K (+100.0%) | 0.10% +0.095 pp | 0.00% +0.000 pp | USD6.51 +0.0% | 3 qtrs — |
| 63 | SQUAREPOINT OPS LLC | 31.2K +31.2K (+100.0%) | 203.2K +203.2K (+100.0%) | 0.10% +0.095 pp | 0.00% +0.000 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 64 | OMERS ADMINISTRATION CORP | 27.6K +27.6K (+100.0%) | 179.7K +179.7K (+100.0%) | 0.08% +0.084 pp | 0.00% +0.001 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 65 | TREXQUANT INVESTMENT LP | 24.3K +24.3K (+100.0%) | 158.2K +158.2K (+100.0%) | 0.07% +0.074 pp | 0.00% +0.001 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 66 | TWO SIGMA ADVISERS, LP | 20.8K +20.8K (+100.0%) | 135.4K +135.4K (+100.0%) | 0.06% +0.064 pp | 0.00% +0.000 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 67 | ACADIAN ASSET MANAGEMENT LLC | 20.8K -129.4K (-86.1%) | 134.0K -559.0K (-80.7%) | 0.06% -0.395 pp | 0.00% -0.001 pp | USD4.62 +40.9% | 2 qtrs — |
| 68 | AMERICAN CENTURY COMPANIES INC | 15.8K +15.8K (+100.0%) | 102.5K +102.5K (+100.0%) | 0.05% +0.048 pp | 0.00% +0.000 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 69 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 14.6K +14.6K (+100.0%) | 94.9K +94.9K (+100.0%) | 0.04% +0.045 pp | 0.00% +0.003 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 70 | JEFFERIES FINANCIAL GROUP INC. | 13.7K +13.7K (+100.0%) | 89.4K +89.4K (+100.0%) | 0.04% +0.042 pp | 0.00% +0.001 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 71 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 11.2K +5.5K (+94.9%) | 72.9K +46.4K (+174.6%) | 0.03% +0.017 pp | 0.01% +0.003 pp | USD5.11 +27.4% | 5 qtrs — |
| 72 | BANK OF MONTREAL /CAN/ | 10.0K -10.0K (-50.0%) | 65.1K -27.3K (-29.5%) | 0.03% -0.031 pp | 0.00% +0.000 pp | USD4.62 +40.9% | 2 qtrs — |
| 73 | TOWER RESEARCH CAPITAL LLC (TRC) | 9.5K +1.7K (+21.0%) | 61.8K +25.6K (+70.6%) | 0.03% +0.005 pp | 0.00% +0.001 pp | USD7.39 -11.9% | 15 qtrs — |
| 74 | UBS GROUP AG | 8.1K -234.4K (-96.7%) | 52.5K -1.1M (-95.3%) | 0.02% -0.716 pp | 0.00% 0.000 pp | USD4.55 +43.1% | 15 qtrs — |
| 75 | JPMORGAN CHASE & CO | 5.2K +3.1K (+141.0%) | 34.1K +24.1K (+239.5%) | 0.02% +0.009 pp | 0.00% +0.000 pp | USD7.12 -8.6% | 15 qtrs — |
| 76 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 3.3K +2.1K (+163.5%) | 21.8K +15.9K (+271.3%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD5.28 +23.3% | 5 qtrs — |
| 77 | FMR LLC | 1.7K -766.0 (-31.5%) | 10.8K -394.0 (-3.5%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD1.74 +274.1% | 14 qtrs — |
| 78 | GF FUND MANAGEMENT CO. LTD. | 1.4K +671.0 (+98.8%) | 8.8K +5.7K (+180.2%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD4.96 +31.3% | 5 qtrs — |
| 79 | ROYAL BANK OF CANADA | 383.00 -4.1K (-91.4%) | 2.0K -19.0K (-90.5%) | 0.00% -0.012 pp | 0.00% +0.000 pp | USD3.41 +90.9% | 14 qtrs — |
| 80 | NISA INVESTMENT ADVISORS, LLC | 195.00 +— (+0.0%) | 1.3K +368.0 (+40.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.28 +408.6% | 4 qtrs — |
| 81 | PARALLEL ADVISORS, LLC | 135.00 +135.0 (+100.0%) | 879.00 +879.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.50 +0.2% | 1 qtrs NEW |
| 82 | — | 121.00 +121.0 (+100.0%) | 788.00 +788.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.001 pp | USD6.50 +0.2% | 1 qtrs NEW |
| 83 | OPTIMA CAPITAL LLC | 108.00 +108.0 (+100.0%) | 703.00 +703.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.51 +0.0% | 1 qtrs NEW |
| 84 | ALLWORTH FINANCIAL LP | 28.00 +28.0 (+100.0%) | 183.00 +183.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.50 +0.2% | 1 qtrs NEW |
| 85 | LARSON FINANCIAL GROUP LLC | 13.00 +13.0 (+100.0%) | 85.00 +85.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.46 +0.8% | 1 qtrs NEW |
| 86 | ADVISOR GROUP HOLDINGS, INC. | 8.00 +8.0 (+100.0%) | 52.00 +52.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.50 +0.2% | 1 qtrs NEW |
| 87 | STEMPOINT CAPITAL LP | — -389.2K (-100.0%) | — -1.8M (-100.0%) | 0.00% -1.188 pp | 0.00% -0.360 pp | USD— | 2 qtrs SOLD |
| 88 | OPALEYE MANAGEMENT INC. | — -75.0K (-100.0%) | — -346.5K (-100.0%) | 0.00% -0.229 pp | 0.00% -0.049 pp | USD— | 6 qtrs SOLD |
| 89 | BURKEHILL GLOBAL MANAGEMENT, LP | — -10.0K (-100.0%) | — -46.2K (-100.0%) | 0.00% -0.031 pp | 0.00% -0.003 pp | USD— | 2 qtrs SOLD |
| 90 | CWM, LLC | — -767.0 (-100.0%) | — -4.0K (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 91 | HEIGHTS CAPITAL MANAGEMENT, INC | — -10.0K (-100.0%) | — -46.2K (-100.0%) | 0.00% -0.031 pp | 0.00% -0.013 pp | USD— | 2 qtrs SOLD |
| 92 | FIFTH LANE CAPITAL, LP | — -70.0K (-100.0%) | — -323.4K (-100.0%) | 0.00% -0.214 pp | 0.00% -0.325 pp | USD— | 2 qtrs SOLD |
| 93 | ECOR1 CAPITAL, LLC | — -800.0K (-100.0%) | — -3.7M (-100.0%) | 0.00% -2.443 pp | 0.00% -0.177 pp | USD— | 2 qtrs SOLD |
| 94 | MONASHEE INVESTMENT MANAGEMENT LLC | — -300.0K (-100.0%) | — -1.4M (-100.0%) | 0.00% -0.916 pp | 0.00% -0.691 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 19 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.02% | 329.4K | 0.60% |
| 2 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.01% | 137.4K | 0.35% |
| 3 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.01% | 9.2K | 0.35% |
| 4 | iShares Biotechnology ETF IBB | 0.01% | 1.07M | 0.44% |
| 5 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.01% | 51.6K | 0.40% |
| 6 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.01% | 8.3K | 0.19% |
| 7 | ProShares Ultra Nasdaq Biotechnology BIB | 0.01% | 5.4K | 1.19% |
| 8 | Avantis U.S. Small Cap Equity ETF AVSC | 0.00% | 99.7K | 0.25% |
| 9 | Vanguard Extended Market ETF VXF | 0.00% | 705.1K | 0.05% |
| 10 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 12.3K | 0.17% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.67
Bullish
Ratio by volume
3.00
Bullish
Buys
10
Sells
6
Shares acquired
1.86M
Shares disposed
9.2K
Cash buys
—
Cash sales
6.00
Net activity
+1,853,567
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | Kasraian Kasra | Officer | S-Sale | D | Common Stock | 1,233 | 1.41 | 1.7K | 50,074 | D | ↗ |
| 2026-03-04 | STRECK PAUL | Officer | S-Sale | D | Common Stock | 1,832 | 6.23 | 11.4K | 76,273 | D | ↗ |
| 2026-03-04 | McArthur James G | Director / Officer | S-Sale | D | Common Stock | 5,144 | 6.23 | 32.0K | 296,457 | D | ↗ |
| 2026-03-04 | Donnelly Noel | Officer | S-Sale | D | Common Stock | 2,032 | 6.23 | 12.7K | 111,655 | D | ↗ |
| 2026-03-01 | Vittiglio Joseph | Officer | A-Award | A | Common Stock | 30,717 | 0.00 | — | 65,717 | D | ↗ |
| 2026-03-01 | STRECK PAUL | Officer | A-Award | A | Stock Option (Right to Buy) | 196,500 | 6.22 | 1.22M | 196,500 | D | ↗ |
| 2026-03-01 | McArthur James G | Director / Officer | A-Award | A | Common Stock | 187,688 | 0.00 | — | 301,601 | D | ↗ |
| 2026-03-01 | Kasraian Kasra | Officer | A-Award | A | Common Stock | 34,557 | 0.00 | — | 51,307 | D | ↗ |
| 2026-03-01 | Donnelly Noel | Officer | A-Award | A | Common Stock | 76,793 | 0.00 | — | 113,687 | D | ↗ |
| 2025-12-08 | Vittiglio Joseph | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-11-04 | STRECK PAUL | Officer | D-Return | D | Stock Option (Right to Buy) | 40,000 | 9.83 | 393.2K | 0 | D | ↗ |
| 2025-11-04 | McArthur James G | Director / Officer | D-Return | D | Stock Option (Right to Buy) | 466,095 | 12.00 | 5.59M | 0 | D | ↗ |
| 2025-11-04 | Donnelly Noel | Officer | D-Return | D | Stock Option (Right to Buy) | 144,000 | 16.62 | 2.39M | 0 | D | ↗ |
| 2025-09-30 | Oxford Science Enterprises plc | 10% Owner | P-Purchase | A | Common Stock | 200,000 | 3.20 | 640.0K | 4,955,388 | D | ↗ |
| 2025-09-26 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 9,375,000 | 3.20 | 30.00M | 18,554,273 | I | ↗ |
| 2025-06-04 | Resnick Joshua | Director | A-Award | A | Stock Option (Right to Buy) | 16,000 | 1.51 | 24.2K | 16,000 | D | ↗ |
| 2025-06-04 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 16,000 | 1.51 | 24.2K | 16,000 | I | ↗ |
| 2025-06-04 | Mayer Howard | Director | A-Award | A | Stock Option (Right to Buy) | 16,000 | 1.51 | 24.2K | 16,000 | D | ↗ |
| 2025-06-04 | KEATING LAURIE | Director | A-Award | A | Stock Option (Right to Buy) | 16,000 | 1.51 | 24.2K | 16,000 | D | ↗ |
| 2025-06-04 | HENSON HEIDI | Director | A-Award | A | Stock Option (Right to Buy) | 16,000 | 1.51 | 24.2K | 16,000 | D | ↗ |
| 2025-06-04 | Dable Habib J | Director | A-Award | A | Stock Option (Right to Buy) | 16,000 | 1.51 | 24.2K | 16,000 | D | ↗ |
| 2025-05-30 | STRECK PAUL | Officer | P-Purchase | A | Common Stock | 8,375 | 1.24 | 10.4K | 27,805 | D | ↗ |
| 2025-05-20 | Kasraian Kasra | Officer | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.58 | 118.5K | 75,000 | D | ↗ |
| 2025-04-17 | McArthur James G | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 1.36 | 13.6K | 113,913 | D | ↗ |
| 2025-04-08 | McArthur James G | Director / Officer | P-Purchase | A | Common Stock | 41,500 | 1.15 | 47.7K | 103,913 | D | ↗ |
| 2025-03-27 | Wyman Lisa | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-27 | Finer Mitchell H. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-03 | STRECK PAUL | Officer | A-Award | A | Stock Option (Right to Buy) | 87,000 | 2.81 | 244.5K | 87,000 | D | ↗ |
| 2025-03-03 | McArthur James G | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 271,875 | 2.81 | 764.0K | 271,875 | D | ↗ |
| 2025-03-03 | Donnelly Noel | Officer | A-Award | A | Stock Option (Right to Buy) | 104,250 | 2.81 | 292.9K | 104,250 | D | ↗ |
| 2025-03-03 | DeLena Mary Beth | Officer | A-Award | A | Stock Option (Right to Buy) | 60,000 | 2.81 | 168.6K | 60,000 | D | ↗ |
| 2025-02-26 | Donnelly Noel | Officer | S-Sale | D | Common Stock | 1,527 | 1.68 | 2.6K | 1,673 | D | ↗ |
| 2025-02-26 | DeLena Mary Beth | Officer | S-Sale | D | Common Stock | 1,432 | 1.68 | 2.4K | 1,568 | D | ↗ |
| 2025-02-24 | Donnelly Noel | Officer | A-Award | A | Common Stock | 3,200 | 0.00 | — | 3,200 | D | ↗ |
| 2025-02-24 | DeLena Mary Beth | Officer | A-Award | A | Common Stock | 3,000 | 0.00 | — | 3,000 | D | ↗ |
| 2024-08-19 | STRECK PAUL | Officer | A-Award | A | Stock Option (Right to Buy) | 40,000 | 9.83 | 393.2K | 242,816 | — | ↗ |
| 2024-07-25 | Mellion Michelle L | Officer | M-Exempt | D | Stock Option (Right to Buy) | 7,571 | 10.21 | 77.3K | 50,000 | — | ↗ |
| 2024-07-24 | Mellion Michelle L | Officer | M-Exempt | D | Stock Option (Right to Buy) | 201 | 10.21 | 2.1K | 57,571 | — | ↗ |
| 2024-07-18 | Mellion Michelle L | Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,625 | 10.21 | 128.9K | 57,772 | — | ↗ |
| 2024-07-16 | Mellion Michelle L | Officer | M-Exempt | D | Stock Option (Right to Buy) | 5,901 | 10.21 | 60.2K | 70,397 | — | ↗ |
| 2024-07-12 | Mellion Michelle L | Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,288 | 10.21 | 33.6K | 76,298 | — | ↗ |
| 2024-07-02 | Mellion Michelle L | Officer | M-Exempt | D | Stock Option (Right to Buy) | 37 | 10.21 | 377.77 | 79,586 | — | ↗ |
| 2024-07-01 | Mellion Michelle L | Officer | M-Exempt | D | Stock Option (Right to Buy) | 875 | 10.21 | 8.9K | 79,623 | — | ↗ |
| 2024-06-24 | Mellion Michelle L | Officer | M-Exempt | A | Common Stock | 9,260 | 10.21 | 94.5K | 9,260 | — | ↗ |
| 2024-06-20 | Resnick Joshua | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 16.80 | 218.4K | 13,000 | — | ↗ |
| 2024-06-20 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 13,000 | 16.80 | 218.4K | 13,000 | — | ↗ |
| 2024-06-20 | Mayer Howard | Director | A-Award | A | Stock Option (Right to Buy) | 8,667 | 16.80 | 145.6K | 8,667 | — | ↗ |
| 2024-06-20 | KEATING LAURIE | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 16.80 | 218.4K | 13,000 | — | ↗ |
| 2024-06-20 | HENSON HEIDI | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 16.80 | 218.4K | 13,000 | — | ↗ |
| 2024-06-20 | Dable Habib J | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 16.80 | 218.4K | 13,000 | — | ↗ |
| 2024-06-20 | Ashton Christopher | Director | A-Award | A | Stock Option (Right to Buy) | 13,000 | 16.80 | 218.4K | 13,000 | — | ↗ |
| 2024-06-12 | Mellion Michelle L | Officer | M-Exempt | D | Stock Option (Right to Buy) | 1,086 | 10.21 | 11.1K | 89,758 | — | ↗ |
| 2024-06-11 | Mellion Michelle L | Officer | M-Exempt | D | Stock Option (Right to Buy) | 500 | 10.21 | 5.1K | 90,844 | — | ↗ |
| 2024-06-06 | Mellion Michelle L | Officer | S-Sale | D | Common Stock | 1,411 | 18.00 | 25.4K | 0 | — | ↗ |
| 2024-06-05 | Mellion Michelle L | Officer | M-Exempt | D | Stock Option (Right to Buy) | 7,245 | 10.21 | 74.0K | 92,755 | — | ↗ |
| 2024-05-17 | Svenstrup Niels | Officer | S-Sale | D | Common Stock | 10,000 | 13.41 | 134.1K | 0 | — | ↗ |
| 2024-03-01 | Svenstrup Niels | Officer | A-Award | A | Stock Option (Right to Buy) | 83,000 | 16.62 | 1.38M | 83,000 | — | ↗ |
| 2024-03-01 | Mellion Michelle L | Officer | A-Award | A | Stock Option (Right to Buy) | 83,000 | 16.62 | 1.38M | 83,000 | — | ↗ |
| 2024-03-01 | McArthur James G | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 16.62 | 4.99M | 300,000 | — | ↗ |
| 2024-03-01 | Donnelly Noel | Officer | A-Award | A | Stock Option (Right to Buy) | 144,000 | 16.62 | 2.39M | 144,000 | — | ↗ |
| 2024-02-09 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 2,557,593 | 10.64 | 27.21M | 9,179,273 | — | ↗ |
| 2024-01-15 | DeLena Mary Beth | Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 6.87 | 858.8K | 125,000 | — | ↗ |
| 2023-11-30 | McArthur James G | Director / Officer | P-Purchase | A | Common Stock | 1,694 | 4.17 | 7.1K | 1,694 | — | ↗ |
| 2023-11-10 | Mayer Howard | Director | A-Award | A | Stock Option (Right to Buy) | 22,686 | 3.86 | 87.6K | 22,686 | — | ↗ |
| 2023-06-22 | Resnick Joshua | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 9.61 | 115.3K | 12,000 | — | ↗ |
| 2023-06-22 | KEATING LAURIE | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 9.61 | 115.3K | 12,000 | — | ↗ |
| 2023-06-22 | HENSON HEIDI | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 9.61 | 115.3K | 12,000 | — | ↗ |
| 2023-06-22 | Dable Habib J | Director | A-Award | A | Stock Option (Right to Buy) | 9,000 | 9.61 | 86.5K | 9,000 | — | ↗ |
| 2023-06-22 | Ashton Christopher | Director | A-Award | A | Stock Option (Right to Buy) | 12,000 | 9.61 | 115.3K | 12,000 | — | ↗ |
| 2023-06-08 | McArthur James G | Director / Officer | M-Exempt | A | Common Stock | 2,381 | 2.71 | 6.5K | 2,381 | — | ↗ |
| 2023-06-07 | McArthur James G | Director / Officer | M-Exempt | A | Common Stock | 8,419 | 2.71 | 22.8K | 8,419 | — | ↗ |
| 2023-06-06 | McArthur James G | Director / Officer | S-Sale | D | Common Stock | 18,150 | 16.18 | 293.7K | 0 | — | ↗ |
| 2023-06-05 | McArthur James G | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 500 | 2.71 | 1.4K | 354,004 | — | ↗ |
| 2023-06-02 | McArthur James G | Director / Officer | S-Sale | D | Common Stock | 1,800 | 16.04 | 28.9K | 0 | — | ↗ |
| 2023-03-24 | Goyal Jaya | Officer | M-Exempt | D | Stock Option (Right to Buy) | 392 | 10.88 | 4.3K | 143,804 | — | ↗ |
| 2023-03-01 | Svenstrup Niels | Officer | A-Award | A | Stock Option (Right to Buy) | 75,000 | 15.25 | 1.14M | 75,000 | — | ↗ |
| 2023-03-01 | Mellion Michelle L | Officer | A-Award | A | Stock Option (Right to Buy) | 20,000 | 15.25 | 305.0K | 95,000 | — | ↗ |
| 2023-03-01 | McArthur James G | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 275,000 | 15.25 | 4.19M | 275,000 | — | ↗ |
| 2023-03-01 | Goyal Jaya | Officer | A-Award | A | Stock Option (Right to Buy) | 75,000 | 15.25 | 1.14M | 75,000 | — | ↗ |
| 2023-03-01 | Donnelly Noel | Officer | A-Award | A | Stock Option (Right to Buy) | 144,000 | 15.25 | 2.20M | 144,000 | — | ↗ |
| 2023-02-08 | Goyal Jaya | Officer | M-Exempt | A | Common Stock | 644 | 10.88 | 7.0K | 644 | — | ↗ |
| 2023-02-07 | Goyal Jaya | Officer | M-Exempt | A | Common Stock | 3,679 | 10.88 | 40.0K | 3,679 | — | ↗ |
| 2023-02-06 | Goyal Jaya | Officer | M-Exempt | D | Stock Option (Right to Buy) | 1,677 | 10.88 | 18.2K | 148,519 | — | ↗ |
| 2022-12-19 | Svenstrup Niels | Officer | M-Exempt | A | Common Stock | 10,000 | 2.71 | 27.1K | 10,000 | — | ↗ |
| 2022-10-03 | Dable Habib J | Director | A-Award | A | Stock Option (Right to Buy) | 22,686 | 0.00 | — | 22,686 | — | ↗ |
| 2022-07-01 | Mellion Michelle L | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2022-05-10 | Shah Rajeev M. | Director | C-Conversion | D | Series B Preferred Stock | 1,508,048 | 0.00 | — | 0 | — | ↗ |
| 2022-05-10 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | C-Conversion | A | Common Stock | 207,672 | 0.00 | — | 207,672 | — | ↗ |
| 2022-05-10 | Oxford Science Enterprises plc | Director | C-Conversion | D | Series B Preferred stock | 1,575,572 | 0.00 | — | 0 | — | ↗ |
| 2022-05-10 | Flynn James E | 10% Owner | C-Conversion | D | Series B Preferred Stock | 273,313 | 0.00 | — | 0 | — | ↗ |
| 2022-05-10 | Deerfield Private Design Fund V, L.P. | Director | C-Conversion | D | Series B Preferred Stock | 273,313 | 0.00 | — | 0 | — | ↗ |
| 2022-05-06 | Svenstrup Niels | Officer | A-Award | A | Stock Option (Right to Buy) | 109,874 | 0.00 | — | 109,874 | — | ↗ |
| 2022-05-06 | Shah Rajeev M. | Director | A-Award | A | Stock Option (Right to Buy) | 11,667 | 0.00 | — | 11,667 | — | ↗ |
| 2022-05-06 | Resnick Joshua | Director | A-Award | A | Stock Option (Right to Buy) | 11,667 | 12.00 | 140.0K | 11,667 | — | ↗ |
| 2022-05-06 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 11,667 | 12.00 | 140.0K | 11,667 | — | ↗ |
| 2022-05-06 | Mellion Michelle L | Officer | A-Award | A | Stock Option (Right to Buy) | 16,655 | 0.00 | — | 16,655 | — | ↗ |
| 2022-05-06 | McArthur James G | Officer | A-Award | A | Stock Option (Right to Buy) | 466,095 | 0.00 | — | 466,095 | — | ↗ |
| 2022-05-06 | KEATING LAURIE | Director | P-Purchase | A | Common Stock | 4,166 | 12.00 | 50.0K | 4,166 | — | ↗ |
| 2022-05-06 | HENSON HEIDI | Director | A-Award | A | Stock Option (Right to Buy) | 11,667 | 0.00 | — | 11,667 | — | ↗ |
| 2022-05-06 | Goyal Jaya | Officer | A-Award | A | Stock Option (Right to Buy) | 79,920 | 0.00 | — | 79,920 | — | ↗ |
| 2022-05-06 | Donnelly Noel | Officer | A-Award | A | Stock Option (Right to Buy) | 169,037 | 0.00 | — | 169,037 | — | ↗ |
| 2022-05-06 | Bracegirdle Sonia | Officer | A-Award | A | Stock Option (Right to Buy) | 79,547 | 0.00 | — | 79,547 | — | ↗ |
| 2022-05-06 | Ashton Christopher | Director | A-Award | A | Stock Option (Right to Buy) | 11,667 | 0.00 | — | 11,667 | — | ↗ |
| 2022-05-05 | Svenstrup Niels | Officer | — | D | Stock Option (Right to Buy) | 84,874 | 8.96 | 760.5K | 0 | — | ↗ |
| 2022-05-05 | Resnick Joshua | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-05-05 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | — | I | Series A-2 Preferred Stock | 207,672 | 0.00 | — | 0 | — | ↗ |
| 2022-05-05 | Oxford Science Enterprises plc | 10% Owner | — | D | Series B Preferred Stock | 1,547,713 | 0.00 | — | 0 | — | ↗ |
| 2022-05-05 | Mellion Michelle L | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-05-05 | McArthur James G | Director / Officer | — | D | Stock Option (Right to Buy) | 356,304 | 2.71 | 965.6K | 0 | — | ↗ |
| 2022-05-05 | KEATING LAURIE | Director | — | D | Stock Option (Right to Buy) | 98,231 | 10.88 | 1.07M | 0 | — | ↗ |
| 2022-05-05 | HENSON HEIDI | Director | — | D | Stock Option (Right to Buy) | 55,009 | 8.96 | 492.9K | 0 | — | ↗ |
| 2022-05-05 | Goyal Jaya | Officer | — | D | Stock Option (Right to Buy) | 150,196 | 10.88 | 1.63M | 0 | — | ↗ |
| 2022-05-05 | Flynn James E | 10% Owner | — | I | Series B Preferred Stock | 268,480 | 0.00 | — | 0 | — | ↗ |
| 2022-05-05 | Donnelly Noel | Officer | — | D | Stock Option (Right to Buy) | 203,339 | 10.88 | 2.21M | 0 | — | ↗ |
| 2022-05-05 | Bracegirdle Sonia | Officer | — | D | Stock Option (Right to Buy) | 19,646 | 11.77 | 231.2K | 0 | — | ↗ |
| 2022-05-05 | Ashton Christopher | Director | — | D | Stock Option (Right to Buy) | 35,630 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
69.17M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | James McArthur, Ph.D. President and Chief Executive Officer | 619.0K | 428.1K | 170.6K | 2.09M | — | 10.5K | 3.32M | 68.11% | ↗ |
| 2 | 2025 | Noel P. Donnelly, M.B.A. Chief Financial Officer | 487.1K | 245.0K | 99.5K | 916.8K | — | 10.5K | 1.76M | 57.78% | ↗ |
| 3 | 2025 | Joseph D. Vittiglio, J.D., Chief Business and Legal Officer | 31.2K | 244.0K | 195.7K | 732.5K | — | 116.4K | 1.32M | 70.33% | ↗ |
| 4 | 2024 | James McArthur, Ph.D. President and Chief Executive Officer | 594.9K | 245.4K | — | 3.58M | — | 10.4K | 4.43M | 80.78% | ↗ |
| 5 | 2024 | Noel P. Donnelly, M.B.A. Chief Financial Officer | 468.4K | 155.0K | — | 1.72M | — | 10.4K | 2.35M | 73.03% | ↗ |
| 6 | 2024 | Paul Streck, M.D., M.B.A. Executive Vice President, Head of Research & Development | 194.9K | 132.0K | — | 1.74M | — | 5.8K | 2.07M | 83.94% | ↗ |
| 7 | 2023 | James McArthur, Ph.D. President and Chief Executive Officer | 572.0K | 228.8K | — | 2.62M | — | 9.9K | 3.43M | 76.33% | ↗ |
| 8 | 2023 | Noel P. Donnelly, M.B.A. Chief Financial Officer | 450.3K | 144.0K | — | 1.37M | — | 9.9K | 1.97M | 69.38% | ↗ |
| 9 | 2023 | Michelle Mellion, M.D. Senior Vice President, Clinical Development | 388.9K | 109.0K | — | 903.4K | — | 9.9K | 1.41M | 64.02% | ↗ |
| 10 | 2022 | James McArthur, Ph.D. President and Chief Executive Officer | 522.3K | 302.5K | — | 3.68M | — | 9.2K | 4.51M | 81.51% | ↗ |
| 11 | 2022 | Noel P. Donnelly, M.B.A. Chief Financial Officer | 433.0K | 208.0K | — | 1.33M | — | 9.2K | 1.98M | 67.23% | ↗ |
| 12 | 2022 | Niels Svenstrup, Ph.D. Senior Vice President, Chemistry, Manufacturing and Controls | 333.0K | 113.0K | — | 866.9K | — | 9.2K | 1.32M | 65.57% | ↗ |
| 13 | 2021 | James McArthur, Ph.D. President and Chief Executive Officer | 407.6K | 190.4K | — | 3.49M | — | — | 4.09M | 85.38% | ↗ |
| 14 | 2021 | Noel P. Donnelly, M.B.A. Chief Financial Officer | 91.2K | 154.8K | — | 1.53M | — | — | 1.78M | 86.14% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| James G. McArthur | President, Chief Executive Officer, Treasurer, Secretary & Director | 1M | — |
| Noel Donnelly | Chief Financial Officer | 742.6K | male |
| Joseph D. Vittiglio | Chief Business & Legal Officer and Secretary | 391.6K | male |
| Paul D. Streck | Executive Vice President and Head of Research & Development | 332.7K | — |
| Melissa Michaels | Executive Director & Head of Regulatory Affairs CMC | — | female |
| Pallavi Lonkar | Vice President & Head of Preclinical | — | female |
| Kasra Kasraian | Chief Technology Officer | — | — |
| Gregory Song | Executive Director & Head of Biometrics | — | male |
| Hayley Parker | Senior Vice President of Global Regulatory Affairs & Quality | — | — |
| Emiko Bryant | Senior Vice President of HR & Administration | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PEPG
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
